Annual Retained Earnings
-$543.28 M
-$75.37 M-16.11%
September 30, 2024
Summary
- As of February 7, 2025, OTLK annual retained earnings is -$543.28 million, with the most recent change of -$75.37 million (-16.11%) on September 30, 2024.
- During the last 3 years, OTLK annual retained earnings has fallen by -$200.40 million (-58.45%).
- OTLK annual retained earnings is now -477.57% below its all-time high of -$94.06 million, reached on September 30, 2014.
Performance
OTLK Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$543.28 M
+$5.69 M+1.04%
September 1, 2024
Summary
- As of February 7, 2025, OTLK quarterly retained earnings is -$543.28 million, with the most recent change of +$5.69 million (+1.04%) on September 1, 2024.
- Over the past year, OTLK quarterly retained earnings has dropped by -$64.19 million (-13.40%).
- OTLK quarterly retained earnings is now -477.57% below its all-time high of -$94.06 million, reached on September 30, 2015.
Performance
OTLK Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
OTLK Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -16.1% | -13.4% |
| 3 y3 years | -58.5% | -58.5% |
| 5 y5 years | -113.5% | -96.3% |
OTLK Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -58.5% | at low | -52.0% | +8.4% |
| 5 y | 5-year | -113.5% | at low | -100.4% | +8.4% |
| alltime | all time | -477.6% | at low | -477.6% | +8.4% |
Outlook Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | -$543.28 M(+16.1%) | - |
| Sep 2024 | - | -$543.28 M(-1.0%) |
| Jun 2024 | - | -$548.98 M(-7.5%) |
| Mar 2024 | - | -$593.39 M(+23.9%) |
| Dec 2023 | - | -$479.10 M(+2.4%) |
| Sep 2023 | -$467.92 M(+14.4%) | -$467.92 M(+2.9%) |
| Jun 2023 | - | -$454.93 M(+4.8%) |
| Mar 2023 | - | -$434.25 M(+1.6%) |
| Dec 2022 | - | -$427.60 M(+4.6%) |
| Sep 2022 | -$408.94 M(+19.3%) | -$408.94 M(+3.6%) |
| Jun 2022 | - | -$394.59 M(+4.7%) |
| Mar 2022 | - | -$377.05 M(+5.5%) |
| Dec 2021 | - | -$357.35 M(+4.2%) |
| Sep 2021 | -$342.88 M(+18.3%) | -$342.88 M(+4.1%) |
| Jun 2021 | - | -$329.48 M(+3.8%) |
| Mar 2021 | - | -$317.28 M(+4.3%) |
| Dec 2020 | - | -$304.18 M(+5.0%) |
| Sep 2020 | -$289.72 M | -$289.72 M(+3.5%) |
| Jun 2020 | - | -$279.80 M(+1.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | -$276.78 M(+2.1%) |
| Dec 2019 | - | -$271.08 M(+6.5%) |
| Sep 2019 | -$254.48 M(+17.6%) | -$254.48 M(+4.1%) |
| Jun 2019 | - | -$244.38 M(+1.9%) |
| Mar 2019 | - | -$239.94 M(+4.5%) |
| Dec 2018 | - | -$229.70 M(+6.2%) |
| Sep 2018 | -$216.31 M(+16.2%) | -$216.31 M(+6.0%) |
| Jun 2018 | - | -$204.11 M(+4.3%) |
| Mar 2018 | - | -$195.68 M(+4.0%) |
| Dec 2017 | - | -$188.14 M(+1.0%) |
| Sep 2017 | -$186.22 M(+26.4%) | -$186.22 M(+3.5%) |
| Jun 2017 | - | -$179.86 M(+3.1%) |
| Mar 2017 | - | -$174.54 M(+4.8%) |
| Dec 2016 | - | -$166.49 M(+13.0%) |
| Sep 2016 | -$147.37 M(+56.7%) | -$147.37 M(+7.7%) |
| Jun 2016 | - | -$136.80 M(+19.5%) |
| Mar 2016 | - | -$114.47 M(+3.2%) |
| Dec 2015 | - | -$110.93 M(+17.9%) |
| Sep 2015 | -$94.06 M(0.0%) | -$94.06 M |
| Sep 2014 | -$94.06 M | - |
FAQ
- What is Outlook Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Outlook Therapeutics?
- What is Outlook Therapeutics annual retained earnings year-on-year change?
- What is Outlook Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Outlook Therapeutics?
- What is Outlook Therapeutics quarterly retained earnings year-on-year change?
What is Outlook Therapeutics annual retained earnings?
The current annual retained earnings of OTLK is -$543.28 M
What is the all time high annual retained earnings for Outlook Therapeutics?
Outlook Therapeutics all-time high annual retained earnings is -$94.06 M
What is Outlook Therapeutics annual retained earnings year-on-year change?
Over the past year, OTLK annual retained earnings has changed by -$75.37 M (-16.11%)
What is Outlook Therapeutics quarterly retained earnings?
The current quarterly retained earnings of OTLK is -$543.28 M
What is the all time high quarterly retained earnings for Outlook Therapeutics?
Outlook Therapeutics all-time high quarterly retained earnings is -$94.06 M
What is Outlook Therapeutics quarterly retained earnings year-on-year change?
Over the past year, OTLK quarterly retained earnings has changed by -$64.19 M (-13.40%)